Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
about
From Inflammation to Prostate Cancer: The Role of InflammasomesImmune Infiltration and Prostate CancerProstate-specific antigen and perfluoroalkyl acids in the C8 health study populationProstate cancer: intriguing data on inflammation and prostate cancer.Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.Prevention of prostate cancer: outcomes of clinical trials and future opportunities.Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey.A Perspective on Prostate Carcinogenesis and ChemopreventionRandomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancerThe role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer.Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis.Racial differences in prostate inflammation: results from the REDUCE study.Does inflammation reduce the risk of prostate cancer?Natriuretic Peptides: The Case of Prostate Cancer.Ursolic acid activates the apoptosis of prostate cancer via ROCK/PTEN mediated mitochondrial translocation of cofilin-1.Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial.Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt.
P2860
Q26739947-107236BE-3881-4562-A182-34610793C257Q26798412-AC141A49-88C0-4BE7-A578-6688E0CC45FFQ28384774-75BCF471-F010-4507-BEC8-8F83E7D89E78Q30834157-1EFA59B6-E68B-45E7-B965-9EC13811FDCEQ33575062-8E990012-17B2-4073-8A93-B3ADDD17D7DBQ35067699-04BB9701-6073-4701-AE51-6A0805092275Q35236584-36CA54A7-0553-4093-BA3E-09B1A9BEB9C3Q36116269-E0FBACD2-4C30-4C16-BFDE-F82F42EDF969Q36132629-12D4BD90-70D1-4C7C-A9AE-B20A555C143AQ36896695-8D5CB57D-F0CD-4A19-AEDE-42EE10C3CDB8Q38211603-42645532-8DDA-43AE-AF0E-B5D791927693Q38795318-0049F0EE-555A-40A9-ACD1-95A056CB8FD0Q40103429-99BE6646-E931-4154-A870-F479AE9BCC60Q40244370-E9240C7D-3216-4063-977D-1B3675BDBB5FQ40967154-0BF60685-A79B-404D-AB39-9D1CF710F515Q41874830-2C6E4951-D1F1-4403-BFF9-12D8B3BA9F57Q42700950-223039B6-3280-4BF6-AFBD-971F29F6C41FQ44001648-13BC2BA0-081E-4A62-A93B-2F241B213F5EQ47849831-104B4712-4FCF-4C0B-9C3B-82EEF1352F6EQ50053239-7B0B2B24-B099-434C-A94C-65CF15810344Q52579829-210823B4-950A-4DF2-ABA5-152B32A6B4D9Q53094230-CF9650EC-2814-480C-9615-F1DC47861299Q53212746-4832BF1B-0B01-463D-8DB6-4571C6AD35F5Q55379481-D15C4715-BAAC-476A-AB5F-A0D71177E0DE
P2860
Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Histological inflammation and ...... ostate cancer screening trial.
@en
type
label
Histological inflammation and ...... ostate cancer screening trial.
@en
prefLabel
Histological inflammation and ...... ostate cancer screening trial.
@en
P2093
P2860
P356
P1433
P1476
Histological inflammation and ...... ostate cancer screening trial.
@en
P2093
Heini Huhtala
Liisa Määttänen
Marita Laurila
Paula M Kujala
Teuvo L J Tammela
Tytti H Yli-Hemminki
P2860
P304
P356
10.1111/BJU.12153
P577
2013-06-07T00:00:00Z